These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2969950

  • 1. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride.
    Hall H, Farde L, Sedvall G.
    J Neural Transm; 1988; 73(1):7-21. PubMed ID: 2969950
    [Abstract] [Full Text] [Related]

  • 2. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
    Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L.
    Neuropsychopharmacology; 1994 Dec; 11(4):245-56. PubMed ID: 7531978
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
    Johansson B, Georgiev V, Fredholm BB.
    Neuroscience; 1997 Oct; 80(4):1187-207. PubMed ID: 9284070
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
    Farde L.
    Psychopharmacology (Berl); 1992 Oct; 107(1):23-9. PubMed ID: 1534178
    [Abstract] [Full Text] [Related]

  • 10. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 11. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 12. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J, Coirini H, Källström L, Wiesel FA, Johnson AE.
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distribution of dopamine D1 and D2 receptors in rabbit cortical areas, hippocampus, and neostriatum in relation to dopamine contents.
    Dewar KM, Reader TA.
    Synapse; 1989 Sep; 4(4):378-86. PubMed ID: 2532424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P, Sunahara RK, Niznik HB.
    Synapse; 1994 May; 17(1):62-4. PubMed ID: 8042146
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M, Hatano K, Sakiyama Y, Kawasumi Y, Kato T, Ito K.
    Synapse; 2001 Sep 15; 41(4):285-93. PubMed ID: 11494399
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.